Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry Poynard

Showing results (161-170 of 272) with videos related to

Pageof 28
Sort By:
Journal of Hepatology|November 14, 2007
Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalitiesGeorgia Malamut, Marianne Ziol, Felipe Suarez, et al.
European Journal of Gastroenterology & Hepatology|December 25, 2004
Long-term therapy with lamivudine in renal transplant recipients with chronic hepatitis BDominique Thabut, Vincent Thibault, Brigitte Bernard-Chabert, et al.
Journal of Clinical Gastroenterology|July 8, 2009
Assessment of liver fibrosis and steatosis in PBC with FibroScan, MRI, MR-spectroscopy, and serum markersMireen Friedrich-Rust, Cindy Müller, Anne Winckler, et al.
Journal of Hepatology|February 28, 2002
Polymorphonuclear neutrophils are a source of hepatocyte growth factor in patients with severe alcoholic hepatitisJulien Taïeb, Charlotte Delarche, Valérie Paradis, et al.
Plos One|December 5, 2008
Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markersThierry Poynard, Patrick Ingiliz, Laure Elkrief, et al.
Journal of Hepatology|April 12, 2002
Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AHPhilippe Mathurin, Charles L Mendenhall, Robert L Carithers, et al.
Clinical Chemistry|August 26, 2006
A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis CYen Ngo, Mona Munteanu, Djamila Messous, et al.
Biomedicines|March 25, 2022
Clinical Interest of Serum Alpha-2 Macroglobulin, Apolipoprotein A1, and Haptoglobin in Patients with Non-Alcoholic Fatty Liver Disease, with and without Type 2 Diabetes, before or during COVID-19Olivier Deckmyn, Thierry Poynard, Pierre Bedossa, et al.
Regulatory Toxicology and Pharmacology : RTP|May 5, 2011
What are the best reference values for a normal serum alanine transaminase activity (ALT)? Impact on the presumed prevalence of drug induced liver injury (DILI)Helmi M'Kada, Mona Munteanu, Hugo Perazzo, et al.
European Journal of Gastroenterology & Hepatology|October 23, 2010
High rate of adefovir-lamivudine combination therapy in nucleoside-naïve patients with chronic hepatitis B in France: results of a national survey in 1730 patientsPatrick Marcellin, Jean-François Cadranel, Thierry Fontanges, et al.
Pageof 28

Showing results (161-170 of 272) with videos related to

Sort By:
Pageof 28
Journal of Hepatology|November 14, 2007
Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalitiesGeorgia Malamut, Marianne Ziol, Felipe Suarez, et al.
European Journal of Gastroenterology & Hepatology|December 25, 2004
Long-term therapy with lamivudine in renal transplant recipients with chronic hepatitis BDominique Thabut, Vincent Thibault, Brigitte Bernard-Chabert, et al.
Journal of Clinical Gastroenterology|July 8, 2009
Assessment of liver fibrosis and steatosis in PBC with FibroScan, MRI, MR-spectroscopy, and serum markersMireen Friedrich-Rust, Cindy Müller, Anne Winckler, et al.
Journal of Hepatology|February 28, 2002
Polymorphonuclear neutrophils are a source of hepatocyte growth factor in patients with severe alcoholic hepatitisJulien Taïeb, Charlotte Delarche, Valérie Paradis, et al.
Plos One|December 5, 2008
Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markersThierry Poynard, Patrick Ingiliz, Laure Elkrief, et al.
Journal of Hepatology|April 12, 2002
Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AHPhilippe Mathurin, Charles L Mendenhall, Robert L Carithers, et al.
Clinical Chemistry|August 26, 2006
A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis CYen Ngo, Mona Munteanu, Djamila Messous, et al.
Biomedicines|March 25, 2022
Clinical Interest of Serum Alpha-2 Macroglobulin, Apolipoprotein A1, and Haptoglobin in Patients with Non-Alcoholic Fatty Liver Disease, with and without Type 2 Diabetes, before or during COVID-19Olivier Deckmyn, Thierry Poynard, Pierre Bedossa, et al.
Regulatory Toxicology and Pharmacology : RTP|May 5, 2011
What are the best reference values for a normal serum alanine transaminase activity (ALT)? Impact on the presumed prevalence of drug induced liver injury (DILI)Helmi M'Kada, Mona Munteanu, Hugo Perazzo, et al.
European Journal of Gastroenterology & Hepatology|October 23, 2010
High rate of adefovir-lamivudine combination therapy in nucleoside-naïve patients with chronic hepatitis B in France: results of a national survey in 1730 patientsPatrick Marcellin, Jean-François Cadranel, Thierry Fontanges, et al.
Pageof 28